From: Apolipoproteins and the risk of giant cell arteritis—a nested case–control study
Cases, n | 100 |
Female sex, n (%) | 81 (81) |
Age at GCA diagnosis, mean, years | 73.6 (SD 6.0) (range 56.9–85.8) |
Time from screening to GCA diagnosis, median, years | 12.0 (IQR 8.5–15.5) (range 0.3–19.1) |
Positive biopsy, na | 63 (63%) |
Fulfilled ACR criteria, n | 92 (92%) |
Visual impairment at diagnosis, n (%) | 41 (41%) |
Large vessel involvement, n (%) | 16 (16%) |
ESR at time of diagnosis, meana | 80.7 (SD 31.5) |
CRP at time of diagnosis, mediana | 89.0 (IQR 50.0–141.8) |
Initial oral glucocorticosteroid dose, median, mgb | 40 (IQR 20–60) |